These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12900169)

  • 1. Potential roles of insulin and IGF-1 in Alzheimer's disease.
    Gasparini L; Xu H
    Trends Neurosci; 2003 Aug; 26(8):404-6. PubMed ID: 12900169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease.
    Carro E; Torres-Aleman I
    Eur J Pharmacol; 2004 Apr; 490(1-3):127-33. PubMed ID: 15094079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease?
    Carro E; Trejo JL; Spuch C; Bohl D; Heard JM; Torres-Aleman I
    Neurobiol Aging; 2006 Nov; 27(11):1618-31. PubMed ID: 16274856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse models of Alzheimer's dementia: current concepts and new trends.
    Torres-Aleman I
    Endocrinology; 2008 Dec; 149(12):5952-7. PubMed ID: 18818286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease.
    O'Neill C; Kiely AP; Coakley MF; Manning S; Long-Smith CM
    Biochem Soc Trans; 2012 Aug; 40(4):721-7. PubMed ID: 22817723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
    Steen E; Terry BM; Rivera EJ; Cannon JL; Neely TR; Tavares R; Xu XJ; Wands JR; de la Monte SM
    J Alzheimers Dis; 2005 Feb; 7(1):63-80. PubMed ID: 15750215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impairment of insulin signaling in Alzheimer's disease.
    Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI
    IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes.
    Yang Y; Ma D; Wang Y; Jiang T; Hu S; Zhang M; Yu X; Gong CX
    J Alzheimers Dis; 2013; 33(2):329-38. PubMed ID: 22936005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications.
    Zemva J; Schubert M
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):322-37. PubMed ID: 24059318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease.
    O' Neill C
    Exp Gerontol; 2013 Jul; 48(7):647-53. PubMed ID: 23470275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease.
    Marcus JN; Schachter J
    J Neurogenet; 2011 Dec; 25(4):127-33. PubMed ID: 22091726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-1 and risk of late-onset Alzheimer's disease: findings from a family study.
    van Exel E; Eikelenboom P; Comijs H; Deeg DJ; Stek ML; Westendorp RG
    Neurobiol Aging; 2014 Mar; 35(3):725.e7-10. PubMed ID: 24054991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
    Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H;
    Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau phosphorylation and assembly.
    Gómez-Ramos A; Smith MA; Perry G; Avila J
    Acta Neurobiol Exp (Wars); 2004; 64(1):33-9. PubMed ID: 15190678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. It may take inflammation, phosphorylation and ubiquitination to 'tangle' in Alzheimer's disease.
    Arnaud L; Robakis NK; Figueiredo-Pereira ME
    Neurodegener Dis; 2006; 3(6):313-9. PubMed ID: 16954650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurofibrillary changes and phosphorylated tau of Alzheimer's disease].
    Takeda M; Kudo T; Taniguchi N; Nishimura T
    Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):169-72. PubMed ID: 8648891
    [No Abstract]   [Full Text] [Related]  

  • 17. Sources of extracellular tau and its signaling.
    Avila J; Simón D; Díaz-Hernández M; Pintor J; Hernández F
    J Alzheimers Dis; 2014; 40 Suppl 1():S7-S15. PubMed ID: 24531154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spreading of tau pathology in Alzheimer's disease by cell-to-cell transmission.
    Mohamed NV; Herrou T; Plouffe V; Piperno N; Leclerc N
    Eur J Neurosci; 2013 Jun; 37(12):1939-48. PubMed ID: 23773063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No correlation between CSF tau protein phosphorylated at threonine 181 with neocortical neurofibrillary pathology in Alzheimer's disease.
    Buerger K; Alafuzoff I; Ewers M; Pirttilä T; Zinkowski R; Hampel H
    Brain; 2007 Oct; 130(Pt 10):e82. PubMed ID: 17615094
    [No Abstract]   [Full Text] [Related]  

  • 20. Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway?
    Lee HG; Ueda M; Zhu X; Perry G; Smith MA
    J Neurosci Res; 2006 Dec; 84(8):1856-61. PubMed ID: 16998902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.